Tumor Cell-Based Vaccine Generated With High Hydrostatic Pressure Synergizes With Radiotherapy by Generating a Favorable Anti-tumor Immune Microenvironment

Turning the corner on therapeutic cancer vaccines

(2019) Robert E. Hollingsworth et al.   npj Vaccines

High hydrostatic pressure in cancer immunotherapy and biomedicine

(2018) Irena Adkins et al.   BIOTECHNOLOGY ADVANCES

Immune-based identification of cancer patients at high risk of progression

(2018) Yann-Alexandre Vano et al.   CURRENT OPINION IN IMMUNOLOGY

Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity

(2018) Lucas Ferrari de Andrade et al.   SCIENCE

Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies

(2018) Michael Rückert et al.   STRAHLENTHERAPIE UND ONKOLOGIE

The Role of Natural Killer T Cells in Cancer—A Phenotypical and Functional Approach

(2018) Daniëlle Krijgsman et al.   Frontiers in Immunology

Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy

(2018) Gang Shi et al.   MOLECULAR THERAPY

Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance

(2017) Norma Bloy et al.   IMMUNOLOGICAL REVIEWS

Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases

(2017) Benjamin Frey et al.   IMMUNOLOGICAL REVIEWS

High hydrostatic pressure affects antigenic pool in tumor cells: Implication for dendritic cell-based cancer immunotherapy

(2017) Linda Urbanova et al.   IMMUNOLOGY LETTERS

TREX1 Cuts Down on Cancer Immunogenicity

(2017) Takahiro Yamazaki et al.   TRENDS IN CELL BIOLOGY

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity

(2017) Claire Vanpouille-Box et al.   Nature Communications

PD-1 blockade at the time of tumor escape potentiates the immune-mediated antitumor effects of a melanoma-targeting monoclonal antibody

(2017) Laetitia They et al.   OncoImmunology

Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure inhibit prostate tumor growth in TRAMP mice

(2017) Romana Mikyskova et al.   OncoImmunology

Trial watch: Immune checkpoint blockers for cancer therapy

(2017) Claire Vanpouille-Box et al.   OncoImmunology

Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy

(2017) Nada Hradilova et al.   PLoS One

Anti-PD-1 inhibits Foxp3+ Treg cell conversion and unleashes intratumoural effector T cells thereby enhancing the efficacy of a cancer vaccine in a mouse model

(2016) Lydia Dyck et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Combination of ionising radiation with hyperthermia increases the immunogenic potential of B16-F10 melanoma cells in vitro and in vivo

(2016) Nina Werthmöller et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions

(2016) F. Pucci et al.   SCIENCE

Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance

(2016) Wenxin Zheng et al.   Oncotarget

Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines

(2016) Lien Vandenberk et al.   Frontiers in Immunology

The dual role of NK cells in antitumor reactions triggered by ionizing radiation in combination with hyperthermia

(2016) Patrick Finkel et al.   OncoImmunology

The role of active vaccination in cancer immunotherapy: lessons from clinical trials

(2015) Haydn T Kissick et al.   CURRENT OPINION IN IMMUNOLOGY

Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy

(2015) ROMANA MIKYŠKOVÁ et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial

(2015) Encouse B Golden et al.   LANCET ONCOLOGY

Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner

(2015) N Werthmöller et al.   Cell Death & Disease

STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors

(2014) Liufu Deng et al.   IMMUNITY

High hydrostatic pressure induces immunogenic cell death in human tumor cells

(2014) Jitka Fucikova et al.   INTERNATIONAL JOURNAL OF CANCER

Clinical use of dendritic cells for cancer therapy

(2014) Sébastien Anguille et al.   LANCET ONCOLOGY

The melanoma revolution: From UV carcinogenesis to a new era in therapeutics

(2014) J. A. Lo et al.   SCIENCE

Antitumor immune responses induced by ionizing irradiation and further immune stimulation

(2013) Benjamin Frey et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

(2012) Alfons JM van den Eertwegh et al.   LANCET ONCOLOGY

Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

(2012) Ravi A Madan et al.   LANCET ONCOLOGY

Characterization of Human γδ T Lymphocytes Infiltrating Primary Malignant Melanomas

(2012) Adriana Cordova et al.   PLoS One

Selected anti-tumor vaccines merit a place in multimodal tumor therapies

(2012) Eva-Maria Weiss et al.   Frontiers in Oncology

Ex vivo- and in vivo-induced dead tumor cells as modulators of antitumor responses

(2010) Eva-Maria Weiss et al.   Annals of the New York Academy of Sciences

Cellular Vaccine Approaches

(2010) Dung T. Le et al.   CANCER JOURNAL

High hydrostatic pressure treatment generates inactivated mammalian tumor cells with immunogeneic features

(2010) E. M. Weiss et al.   Journal of Immunotoxicology

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

(2009) M. Ahmadzadeh et al.   BLOOD

Cells Under Pressure – Treatment of Eukaryotic Cells with High Hydrostatic Pressure, from Physiologic Aspects to Pressure Induced Cell Death

(2008) Benjamin Frey et al.   CURRENT MEDICINAL CHEMISTRY